- Home
- INUV vs ACHL Comparison
INUV vs ACHL Comparison
Compare INUV & ACHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INUV
- ACHL
- Stock Information
- Founded
- INUV N/A
- ACHL 2016
- Country
- INUV United States
- ACHL United Kingdom
- Employees
- INUV N/A
- ACHL N/A
- Industry
- INUV Advertising
- ACHL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INUV Consumer Discretionary
- ACHL Health Care
- Exchange
- INUV Nasdaq
- ACHL Nasdaq
- Market Cap
- INUV 40.4M
- ACHL 29.0M
- IPO Year
- INUV N/A
- ACHL 2021
- Fundamental
- Price
- INUV $0.26
- ACHL $0.71
- Analyst Decision
- INUV Strong Buy
- ACHL Hold
- Analyst Count
- INUV 1
- ACHL 3
- Target Price
- INUV $1.00
- ACHL $2.83
- AVG Volume (30 Days)
- INUV 331.3K
- ACHL 49.8K
- Earning Date
- INUV 08-08-2024
- ACHL 08-14-2024
- Dividend Yield
- INUV N/A
- ACHL N/A
- EPS Growth
- INUV N/A
- ACHL N/A
- EPS
- INUV N/A
- ACHL N/A
- Revenue
- INUV $80,645,465.00
- ACHL N/A
- Revenue This Year
- INUV $16.92
- ACHL N/A
- Revenue Next Year
- INUV $26.08
- ACHL N/A
- P/E Ratio
- INUV N/A
- ACHL N/A
- Revenue Growth
- INUV 28.33
- ACHL N/A
- 52 Week Low
- INUV $0.12
- ACHL $0.63
- 52 Week High
- INUV $0.57
- ACHL $1.76
- Technical
- Relative Strength Index (RSI)
- INUV 42.77
- ACHL 35.91
- Support Level
- INUV $0.25
- ACHL $0.70
- Resistance Level
- INUV $0.29
- ACHL $0.72
- Average True Range (ATR)
- INUV 0.02
- ACHL 0.04
- MACD
- INUV -0.00
- ACHL -0.00
- Stochastic Oscillator
- INUV 13.20
- ACHL 54.05
About INUV Inuvo Inc.
Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications, and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
About ACHL Achilles Therapeutics plc
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.